Research Output per year
Research Output per year
Personal profile
Research Interests
Dr. Hirai's research interest focus on Lung and vascular progenitor cells/stem cells and the molecular mechanisms of Lung and vascular disease.
Dr. Hirai joined Northwestern University in July 2018 from University of Michigan, Ann Arbor. Dr. Hirai completed his postdoctoral training in Molecular pharmacology and Stem cell biology at Northwestern University, Chicago and University of Minnesota, Twin Cities.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Biochemistry, Tokyo Medical and Dental University
… → 2003
Research interests keywords
- Biotechnology
- Cardiovascular Diseases
- Cell Biology
- Lung Injury
- Stem Cells
- Vascular Biology
Fingerprint
Dive into the research topics where Hiroyuki Hirai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Characterization of perivascular alveolar epithelial stem cells and their niche in lung homeostasis and cancer
Chen, Q., Hirai, H., Chan, M., Zhang, J., Cho, M., Randell, S. H., Kadur Lakshminarasimha Murthy, P., Rehman, J. & Liu, Y., Jun 11 2024, In: Stem cell reports. 19, 6, p. 890-905 16 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
MEF2C/p300-mediated epigenetic remodeling promotes the maturation of induced cardiomyocytes
Kojima, H., Sadahiro, T., Muraoka, N., Yamakawa, H., Hashimoto, H., Ishii, R., Gosho, M., Abe, Y., Yamada, Y., Nakano, K., Honda, S., Fujita, R., Akiyama, T., Sunagawa, Y., Morimoto, T., Tsukahara, T., Hirai, H., Fukuda, K. & Ieda, M., Jun 13 2023, In: Stem cell reports. 18, 6, p. 1274-1283 10 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay
Hirai, H., Liang, X., Sun, Y., Zhang, Y., Zhang, J., Chen, Y. E., Mou, H., Zhao, Y. & Xu, J., Mar 10 2022, In: Molecular Therapy Methods and Clinical Development. 24, p. 11-19 9 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Efficient Gene Editing at Major CFTR Mutation Loci
Ruan, J., Hirai, H., Yang, D., Ma, L., Hou, X., Jiang, H., Wei, H., Rajagopalan, C., Mou, H., Wang, G., Zhang, J., Li, K., Chen, Y. E., Sun, F. & Xu, J., Jun 7 2019, In: Molecular Therapy Nucleic Acids. 16, p. 73-81 9 p.Research output: Contribution to journal › Article › peer-review
Open Access70 Scopus citations -
Direct reprogramming of fibroblasts into smooth muscle-like cells with defined transcription factors-brief report
Hirai, H., Yang, B., Garcia-Barrio, M. T., Rom, O., Ma, P. X., Zhang, J. & Chen, Y. E., 2018, In: Arteriosclerosis, thrombosis, and vascular biology. 38, 9, p. 2191-2197 7 p.Research output: Contribution to journal › Article › peer-review
Open Access20 Scopus citations